Structures by: Ananthnag G. S.
Total: 29
C140H122Br4Ni4O8P8,2(CH2Cl2)
C140H122Br4Ni4O8P8,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 39 14632-14641
a=28.0679(15)Å b=21.8228(12)Å c=25.4931(14)Å
α=90° β=114.0480(10)° γ=90°
C140H124Br4O8P8Pd4
C140H124Br4O8P8Pd4
Dalton transactions (Cambridge, England : 2003) (2019) 48, 39 14632-14641
a=27.9334(7)Å b=21.8518(4)Å c=26.0254(5)Å
α=90° β=114.2120(10)° γ=90°
C30H59IN6O2P4Pd,2(CHCl3)
C30H59IN6O2P4Pd,2(CHCl3)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 8 3785-3793
a=15.3398(15)Å b=16.6898(17)Å c=18.9655(19)Å
α=90° β=94.375(2)° γ=90°
C30H59IN6NiO2P4,2(CHCl3)
C30H59IN6NiO2P4,2(CHCl3)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 8 3785-3793
a=16.6214(16)Å b=15.2055(15)Å c=19.0941(19)Å
α=90° β=91.5300(10)° γ=90°
C60H120Br4Cu4I2N12O5P8Pd2,CH2Cl2
C60H120Br4Cu4I2N12O5P8Pd2,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 8 3785-3793
a=15.4735(8)Å b=19.4221(10)Å c=17.5182(9)Å
α=90° β=113.4600(10)° γ=90°
C60H118Cu4I6N12O4P8Pd2
C60H118Cu4I6N12O4P8Pd2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 8 3785-3793
a=15.390(4)Å b=19.203(5)Å c=18.045(5)Å
α=90° β=111.990(4)° γ=90°
C30H59IN6O2P4
C30H59IN6O2P4
Dalton transactions (Cambridge, England : 2003) (2015) 44, 8 3785-3793
a=28.754(3)Å b=8.4632(8)Å c=16.4274(15)Å
α=90° β=90° γ=90°
C22H33Cu2I2N5O2P2
C22H33Cu2I2N5O2P2
Dalton Transactions (2014)
a=10.4251(7)Å b=22.1496(14)Å c=12.9548(8)Å
α=90° β=97.5610(10)° γ=90°
C56H57Cu2I2N3O8P2
C56H57Cu2I2N3O8P2
Dalton Transactions (2014)
a=10.9180(9)Å b=23.2001(18)Å c=24.1557(19)Å
α=65.1230(10)° β=81.6110(10)° γ=86.2930(10)°
C58H57Cu2I2N3O8P2,C2H3N
C58H57Cu2I2N3O8P2,C2H3N
Dalton Transactions (2014)
a=12.4841(3)Å b=17.0323(4)Å c=27.1967(7)Å
α=90° β=94.464(2)° γ=90°
4-[1,3-di-<i>tert</i>-butyl-4-(4,4-dimethylpiperazin-4-ium-1- yl)-2,4-diselanylidene-1,3,2λ^5^,4λ^5^-diazadiphosphedin-2- yl]-1,1-dimethylpiperazin-1-ium iodide hydrate
C20H47N6P2Se2,0.5(OH2),2I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=32.556(3)Å b=9.5372(10)Å c=21.679(2)Å
α=90° β=107.558(2)° γ=90°
1,3-Di-<i>tert</i>-butyl-2,4-bis-<i>tert</i>-butylamino- 2-methyl-4-selenoxo-4λ^5^-[1,3,2,4]diazadiphosphetidin- 2-ium iodide toluene solvate
C24H49N4P2Se,I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=9.3436(6)Å b=10.3905(7)Å c=16.7060(13)Å
α=93.176(1)° β=104.556(1)° γ=91.995(1)°
1,3-Di-<i>tert</i>-butyl-2,4-diselenoxy-2λ^5^,4λ^5^- [1,3,2,4]diazadiphosphetidin-2,4-di(yloxyethyl trimethylammonium) Iodode Hydrate
C18H44N4O2P2Se2,2(I),H2O
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=12.1752(9)Å b=14.2395(11)Å c=36.578(3)Å
α=90° β=94.6320(10)° γ=90°
Iodo(2,2-bipyridine-κN:κN')(1,3-di-<i>tert</i>- butyl-2,4-bis(<i>tert</i>-butylamino)-2-methyl-[1,3,2,4] diazadiphosphetidin-2-ium-κP)copper(I) Iodide
C27H49CuIN6P2,I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=14.1715(6)Å b=14.6142(6)Å c=16.8817(7)Å
α=90° β=90° γ=90°
Μ-Triiodobis(1,3-di(<i>tert</i>-butyl)-2,4-bis(<i>tert</i>- butylamino)-2-methyl-[1,3,2,4]diazadiphosphetidin- 2-ium)-κ-P dicopper(I) iodide acetonitrile solvate
C34H82Cu2I3N8P4,C2H3N,I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=10.3950(7)Å b=29.9149(18)Å c=17.8929(11)Å
α=90° β=95.847(1)° γ=90°
Iodo(1,10-phenanthroline-κN:κN)(1,3-di-<i>tert</i>- butyl-2,4-bis(<i>tert</i>-butylamino)-2-methyl-[1,3,2,4] diazadiphosphetidin-2-ium-κP)copper(I) Iodide
C29H49CuIN6P2,I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=24.7202(11)Å b=10.1169(4)Å c=14.2381(6)Å
α=90° β=90° γ=90°
Chlorido{1,3-di-tert-butylbis(tert-butylamino)-2-methyl-1,3,2,4- diazadiphosphetidin-2-ium}gold(I) trifluoromethanesulfonate
C17H41AuClN4P2,CF3O3S
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=9.714(3)Å b=10.396(3)Å c=17.440(6)Å
α=81.865(4)° β=85.488(4)° γ=62.617(4)°
C30H60N6O2P4
C30H60N6O2P4
Inorganic Chemistry (2012) 51, 5919-5930
a=26.304(9)Å b=9.647(3)Å c=15.030(5)Å
α=90.00° β=98.622(5)° γ=90.00°
C56H88N8O8P8
C56H88N8O8P8
Inorganic Chemistry (2012) 51, 5919-5930
a=14.0072(15)Å b=9.5032(10)Å c=25.390(3)Å
α=90.00° β=97.656(2)° γ=90.00°
8(C30H60ClCuN6O2P4),4(C2H3N),C2H4Cl4
8(C30H60ClCuN6O2P4),4(C2H3N),C2H4Cl4
Inorganic Chemistry (2012) 51, 5919-5930
a=19.742(2)Å b=13.3563(16)Å c=33.573(4)Å
α=90.00° β=90.00° γ=90.00°
C30H60BrCuN6O2P4
C30H60BrCuN6O2P4
Inorganic Chemistry (2012) 51, 5919-5930
a=10.8133(10)Å b=26.476(2)Å c=16.7607(15)Å
α=90.00° β=90.645(1)° γ=90.00°
C28H44N4O4P4Se4
C28H44N4O4P4Se4
Inorganic Chemistry (2012) 51, 5919-5930
a=12.0127(6)Å b=13.9234(7)Å c=11.9517(6)Å
α=90.00° β=110.451(1)° γ=90.00°
C28H44N4O4P4
C28H44N4O4P4
Inorganic Chemistry (2012) 51, 5919-5930
a=18.0803(18)Å b=10.1715(10)Å c=18.0946(18)Å
α=90.00° β=103.199(1)° γ=90.00°
C36H69Cu4I4N9O2P4,0.06(C4H8Cl8),C2H3N
C36H69Cu4I4N9O2P4,0.06(C4H8Cl8),C2H3N
Inorganic Chemistry (2012) 51, 5919-5930
a=38.942(5)Å b=11.0604(13)Å c=32.778(4)Å
α=90.00° β=119.582(1)° γ=90.00°
C84H70Cl5Cu3N8P6
C84H70Cl5Cu3N8P6
Inorganic chemistry (2015) 54, 22 10985-10992
a=17.5311(3)Å b=17.5311(3)Å c=23.1240(4)Å
α=90° β=90° γ=120°
Tris(diphenylphosphanyl)-1,3,5-triazine
C39H30N3P3
Inorganic chemistry (2015) 54, 22 10985-10992
a=10.2469(2)Å b=13.8978(3)Å c=23.3456(4)Å
α=89.790(1)° β=79.542(1)° γ=84.910(1)°
C80H63Cu3I3N7P6,C2H3N
C80H63Cu3I3N7P6,C2H3N
Inorganic chemistry (2015) 54, 22 10985-10992
a=13.298(3)Å b=27.696(6)Å c=21.440(5)Å
α=90° β=98.260(3)° γ=90°
C75H54Cu3I3N9P3
C75H54Cu3I3N9P3
Inorganic chemistry (2015) 54, 22 10985-10992
a=11.5209(12)Å b=15.8765(17)Å c=24.201(3)Å
α=75.258(1)° β=86.507(1)° γ=74.065(1)°
C79H62Br3ClCu3N6P6
C79H62Br3ClCu3N6P6
Inorganic chemistry (2015) 54, 22 10985-10992
a=17.192(4)Å b=18.254(4)Å c=24.392(5)Å
α=90.00° β=101.724(3)° γ=90.00°